Cargando…

A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone

BACKGROUND: Cardiac pathological hypertrophy is associated with a significantly increased risk of coronary heart disease and has been observed in diabetic patients treated with rosiglitazone whereas most published studies do not suggest a similar increase in risk of cardiovascular events in pioglita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verschuren, Lars, Wielinga, Peter Y, Kelder, Thomas, Radonjic, Marijana, Salic, Kanita, Kleemann, Robert, van Ommen, Ben, Kooistra, Teake
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072889/ https://www.ncbi.nlm.nih.gov/pubmed/24938300 http://dx.doi.org/10.1186/1755-8794-7-35

Ejemplares similares

Protective effect of rosiglitazone on kidney function in high-fat challenged human-CRP transgenic mice: a possible role for adiponectin and miR-21?
por: Morrison, Martine C., et al.
Publicado: (2017)

Differential Effects of Drug Interventions and Dietary Lifestyle in Developing Type 2 Diabetes and Complications: A Systems Biology Analysis in LDLr−/− Mice
por: Radonjic, Marijana, et al.
Publicado: (2013)

Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice
por: Mulder, Petra, et al.
Publicado: (2016)

A Dietary Mixture Containing Fish Oil, Resveratrol, Lycopene, Catechins, and Vitamins E and C Reduces Atherosclerosis in Transgenic Mice(2)
por: Verschuren, Lars, et al.
Publicado: (2011)

A Systems Biology Strategy for Predicting Similarities and Differences of Drug Effects: Evidence for Drug-specific Modulation of Inflammation in Atherosclerosis
por: Kleemann, Robert, et al.
Publicado: (2011)

A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice
por: Schoemaker, Marieke H., et al.
Publicado: (2017)

Network signatures link hepatic effects of anti-diabetic interventions with systemic disease parameters
por: Kelder, Thomas, et al.
Publicado: (2014)

Time-Resolved and Tissue-Specific Systems Analysis of the Pathogenesis of Insulin Resistance
por: Kleemann, Robert, et al.
Publicado: (2010)

Beneficial Effects of Alternate Dietary Regimen on Liver Inflammation, Atherosclerosis and Renal Activation
por: Wielinga, Peter Y., et al.
Publicado: (2011)

Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice
por: Salic, Kanita, et al.
Publicado: (2019)

Exploring pathway interactions in insulin resistant mouse liver
por: Kelder, Thomas, et al.
Publicado: (2011)

Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis
por: Salic, Kanita, et al.
Publicado: (2019)

Current and Future Nutritional Strategies to Modulate Inflammatory Dynamics in Metabolic Disorders
por: van den Brink, Willem, et al.
Publicado: (2019)

Cytokines and atherosclerosis: a comprehensive review of studies in mice
por: Kleemann, Robert, et al.
Publicado: (2008)

Coordinated and Interactive Expression of Genes of Lipid Metabolism and Inflammation in Adipose Tissue and Liver during Metabolic Overload
por: Liang, Wen, et al.
Publicado: (2013)

A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology
por: van den Hoek, Anita M., et al.
Publicado: (2020)

Beneficial Effects of an Alternating High- Fat Dietary Regimen on Systemic Insulin Resistance, Hepatic and Renal Inflammation and Renal Function
por: Yakala, Gopala K., et al.
Publicado: (2012)

Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR−/−.Leiden mice
por: Morrison, M C, et al.
Publicado: (2016)

Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil
por: Morrison, Martine C., et al.
Publicado: (2015)

Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD
por: Gart, Eveline, et al.
Publicado: (2018)

A Combined Transcriptomics and Lipidomics Analysis of Subcutaneous, Epididymal and Mesenteric Adipose Tissue Reveals Marked Functional Differences
por: Caesar, Robert, et al.
Publicado: (2010)

Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine
por: Mueller, Andrea M., et al.
Publicado: (2021)

Improving the analysis of designed studies by combining statistical modelling with study design information
por: Thissen, Uwe, et al.
Publicado: (2009)

Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity
por: Mulder, P, et al.
Publicado: (2016)

MicroRNAs as Biomarkers for Myocardial Infarction
por: Salic, Kanita, et al.
Publicado: (2012)

A user-friendly workflow for analysis of Illumina gene expression bead array data available at the arrayanalysis.org portal
por: Eijssen, Lars M.T., et al.
Publicado: (2015)

Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis
por: Kleemann, Robert, et al.
Publicado: (2007)

Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells
por: Gart, Eveline, et al.
Publicado: (2021)

Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice
por: Morrison, Martine C., et al.
Publicado: (2018)

cyNeo4j: connecting Neo4j and Cytoscape
por: Summer, Georg, et al.
Publicado: (2015)

Semi-automated non-target processing in GC × GC–MS metabolomics analysis: applicability for biomedical studies
por: Koek, Maud M., et al.
Publicado: (2010)

Prolonged high-fat diet induces gradual and fat depot-specific DNA methylation changes in adult mice
por: Zwamborn, Ramona A. J., et al.
Publicado: (2017)

Filling gaps in PPAR-alpha signaling through comparative nutrigenomics analysis
por: Cavalieri, Duccio, et al.
Publicado: (2009)

Bioinformatics for the NuGO proof of principle study: analysis of gene expression in muscle of ApoE3*Leiden mice on a high-fat diet using PathVisio
por: Coort, Susan L. M., et al.
Publicado: (2008)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Effect of body fat distribution on the transcription response to dietary fat interventions
por: Radonjic, Marijana, et al.
Publicado: (2009)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia
por: Wagner, Allon, et al.
Publicado: (2015)

Evaluation of multiple variate selection methods from a biological perspective: a nutrigenomics case study
por: Tapp, Henri S., et al.
Publicado: (2012)

The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice
por: Gart, Eveline, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nfetl7h3as9brcgquigoc9jf6u